Clinical Information Search
Search Results for "diabetes_articles"
- Online Learning Center (0)
- Policy Library (103)
- Performance Measures (0)
- Annals of Internal Medicine (1952)
- Annals of Internal Medicine: Clinical Cases (143)
- IM Matters (6)
- ACP Hospitalist (42)
- ACP Diabetes Monthly (58)
- ACP Gastroenterology Monthly (4)
Sorry, no results were found for "diabetes_articles" in Online Learning Center.
Sorry, no results were found for "diabetes_articles" in Performance Measures.
Displaying 201 - 210 of 1952 in Annals of Internal Medicine
These Annals of Internal Medicine results only contain recent articles.
- Visit annals.org to search all content back to 1927.
- View Annals of Internal Medicine CME by topic here.
Review: Metformin is linked to reduced mortality in type 2 diabetes with comorbid CKD and CHF
Source Citation Crowley MJ, Diamantidis CJ, McDuffie JR, et al. Clinical outcomes of metformin use in populations with chronic kidney disease, congestive heart failure, or chronic liver disease: a systematic review. Ann Intern Med. 2017:166;191-200. 28055049
Guideline: In type 2 diabetes, ACP recommends metformin monotherapy if drugs are needed for glycemic control
Source Citation Qaseem A, Barry MJ, Humphrey LL, Forciea MA, Clinical Guidelines Committee of the American College of Physicians. Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline update from the American College of Physicians. Ann Intern Med. 2017;166:279-90. 28055075
Review: Long-term dual-antiplatelet therapy (DAPT) after PCI is no better than short-term DAPT, even with diabetes
Source Citation Gargiulo G, Windecker S, da Costa BR, et al. Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials. BMJ. 2016;355:i5483. 27811064
Semaglutide reduced a composite of CV events at 2 years in patients with type 2 diabetes and high CV risk
Source Citation Marso SP, Bain SC, Consoli A, et al; SUSTAIN-6 Investigators. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016. [Epub ahead of print]. 27633186
Review: In type 2 diabetes, sodium–glucose cotransporter 2 inhibitors do not increase major CV events or mortality
Source Citation Tang H, Fang Z, Wang T, et al. Meta-analysis of effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular outcomes and all-cause mortality among patients with type 2 diabetes mellitus. Am J Cardiol. 2016;118:1774-80. 27666177
In type 2 diabetes treated with high-dose insulin, liraglutide reduced HBA1c
Source Citation Vanderheiden A, Harrison L, Warshauer J, et al. Effect of adding liraglutide vs placebo to a high-dose insulin regimen in patients with type 2 diabetes: a randomized clinical trial. JAMA Intern Med. 2016;176:939-47. 27273731
In patients with type 2 diabetes and CVD, empagliflozin reduced incident or worsening nephropathy at 3.1 y
Source Citation Wanner C, Inzucchi SE, Lachin JM, et al; EMPA-REG OUTCOME Investigators. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med. 2016;375:323-34. 27299675
In patients with type 2 diabetes and high CV risk, liraglutide reduced a composite CV outcome at a median 3.8 y
Source Citation Marso SP, Daniels GH, Brown-Frandsen K, et al; LEADER Steering Committee; LEADER Trial Investigators. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375:311-22. 27295427
Intensive glucose-lowering in type 2 diabetes was linked to hypoglycemia in high-complexity patients
Source Citation McCoy RG, Lipska KJ, Yao X, et al. Intensive treatment and severe hypoglycemia among adults with type 2 diabetes. JAMA Intern Med. 2016; 176:969-78. 27273792
Review: In type 2 diabetes, adding dipeptidyl peptidase-4 inhibitors to sulphonylureas increases hypoglycemia
Source Citation Salvo F, Moore N, Arnaud M, et al. Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis. BMJ. 2016;353:i2231. 27142267